Is Troriluzole Developed By Biohaven Pharmaceuticals
Is troriluzole developed by Biohaven pharmaceuticals? Troriluzole hydrochloride is under clinical development by Biohaven and currently in Phase III for Obsessive-Compulsive Disorder. According to GlobalData, Phase III drugs for Obsessive-Compulsive Disorder does not have sufficient historical data to build an indication benchmark PTSR for Phase III. What is Troriluzole used for? Troriluzole is a tripeptide […]
Is Troriluzole Developed By Biohaven Pharmaceuticals Read More »